JP2005508936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005508936A5 JP2005508936A5 JP2003533847A JP2003533847A JP2005508936A5 JP 2005508936 A5 JP2005508936 A5 JP 2005508936A5 JP 2003533847 A JP2003533847 A JP 2003533847A JP 2003533847 A JP2003533847 A JP 2003533847A JP 2005508936 A5 JP2005508936 A5 JP 2005508936A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- skin
- salicylate
- phytosphingosine
- hinokitiol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 14
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 claims 12
- 229960001860 salicylate Drugs 0.000 claims 7
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims 7
- 230000000699 topical effect Effects 0.000 claims 7
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 claims 6
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 claims 6
- 150000004676 glycans Chemical class 0.000 claims 6
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 claims 6
- 229940033329 phytosphingosine Drugs 0.000 claims 6
- 229920001282 polysaccharide Polymers 0.000 claims 6
- 239000005017 polysaccharide Substances 0.000 claims 6
- 201000004700 rosacea Diseases 0.000 claims 6
- 229930007845 β-thujaplicin Natural products 0.000 claims 6
- 241000124001 Alcyonacea Species 0.000 claims 5
- 241001303601 Rosacea Species 0.000 claims 5
- 244000269722 Thea sinensis Species 0.000 claims 5
- 239000003963 antioxidant agent Substances 0.000 claims 5
- 230000003078 antioxidant effect Effects 0.000 claims 5
- 235000009569 green tea Nutrition 0.000 claims 5
- 239000004615 ingredient Substances 0.000 claims 5
- 239000002085 irritant Substances 0.000 claims 5
- 150000004492 retinoid derivatives Chemical class 0.000 claims 5
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims 4
- 241000283707 Capra Species 0.000 claims 3
- 230000001575 pathological effect Effects 0.000 claims 3
- 206010043189 Telangiectasia Diseases 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 claims 2
- 230000000845 anti-microbial effect Effects 0.000 claims 2
- 239000004599 antimicrobial Substances 0.000 claims 2
- 239000002537 cosmetic Substances 0.000 claims 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 229960004889 salicylic acid Drugs 0.000 claims 2
- 208000009056 telangiectasis Diseases 0.000 claims 2
- 235000014653 Carica parviflora Nutrition 0.000 claims 1
- 241000243321 Cnidaria Species 0.000 claims 1
- 230000007794 irritation Effects 0.000 claims 1
- 150000003902 salicylic acid esters Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/971,561 US6680062B2 (en) | 2001-10-05 | 2001-10-05 | Anti-irritating rosacea treatment |
| PCT/US2002/029722 WO2003030813A2 (en) | 2001-10-05 | 2002-09-18 | Anti-irritating rosacea treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006225842A Division JP2006306899A (ja) | 2001-10-05 | 2006-08-22 | 抗刺激性酒さ治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005508936A JP2005508936A (ja) | 2005-04-07 |
| JP2005508936A5 true JP2005508936A5 (OSRAM) | 2006-01-05 |
| JP3921202B2 JP3921202B2 (ja) | 2007-05-30 |
Family
ID=25518547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003533847A Expired - Fee Related JP3921202B2 (ja) | 2001-10-05 | 2002-09-18 | 抗刺激性酒さ治療 |
| JP2006225842A Pending JP2006306899A (ja) | 2001-10-05 | 2006-08-22 | 抗刺激性酒さ治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006225842A Pending JP2006306899A (ja) | 2001-10-05 | 2006-08-22 | 抗刺激性酒さ治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6680062B2 (OSRAM) |
| EP (1) | EP1441685B1 (OSRAM) |
| JP (2) | JP3921202B2 (OSRAM) |
| AT (1) | ATE414527T1 (OSRAM) |
| AU (1) | AU2002334601B2 (OSRAM) |
| CA (1) | CA2461941C (OSRAM) |
| DE (1) | DE60229971D1 (OSRAM) |
| ES (1) | ES2316647T3 (OSRAM) |
| WO (1) | WO2003030813A2 (OSRAM) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7314634B2 (en) * | 2002-02-22 | 2008-01-01 | Steven Hernandez | Use of polyphenols to treat skin conditions |
| US7851477B2 (en) * | 2003-05-22 | 2010-12-14 | L'oreal | Method for the treatment of skin |
| US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
| US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| US20050020600A1 (en) | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
| CA2545788A1 (en) * | 2003-11-13 | 2005-06-02 | Galileo Pharmaceuticals, Inc. | Plant-derived protein extract compositions and methods |
| AU2005204685B2 (en) * | 2004-01-07 | 2007-06-21 | E-L Management Corporation | Cosmetic composition and method for retarding hair growth |
| US7812049B2 (en) * | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| AU2005203301A1 (en) * | 2004-07-30 | 2006-02-16 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
| DE102005005486A1 (de) * | 2005-02-04 | 2006-08-17 | Schwan-Stabilo Cosmetics Gmbh & Co. Kg | Zubereitung, insbesondere kosmetische Zubereitung sowie ihre Herstellung und Verwendung |
| WO2006134160A2 (en) * | 2005-06-17 | 2006-12-21 | Symrise Gmbh & Co. Kg | Synergistic mixtures of aromatic alcohols and derivatives thereof and tropolone (derivatives) |
| FR2894821B1 (fr) * | 2005-12-15 | 2008-02-29 | Galderma Res & Dev | Compositions comprenant au moins un compose retinoide et au moins un compose anti-irritant et leurs utilisations |
| US8298548B2 (en) | 2007-07-18 | 2012-10-30 | Solazyme, Inc. | Compositions for improving the health and appearance of skin |
| US20070191303A1 (en) * | 2006-01-19 | 2007-08-16 | Solazyme, Inc. | Polysaccharide compositions and methods of producing, screening, and formulating polysaccharide compositions |
| PL3398606T3 (pl) * | 2006-01-19 | 2022-02-07 | Algenist Holdings, Inc, | Kompozycje otrzymane z mikroalg poprawiające zdrowie i wygląd skóry |
| US8277849B2 (en) | 2006-01-19 | 2012-10-02 | Solazyme, Inc. | Microalgae-derived compositions for improving the health and appearance of skin |
| US20070166266A1 (en) * | 2006-01-19 | 2007-07-19 | Solazyme, Inc. | Methods and compositions for improving the health and appearance of skin |
| US20090274736A1 (en) * | 2006-01-19 | 2009-11-05 | Solazyme Inc. | Nutraceutical Compositions From Microalgae And Related Methods of Production And Administration |
| US7381433B1 (en) * | 2007-01-08 | 2008-06-03 | Johnson & Johnson Consumer Companies, Inc. | Compositions containing an extract of a primula denticulata and use thereof |
| WO2009127058A1 (en) * | 2008-04-15 | 2009-10-22 | Immanence Integrale Dermo Correction Inc. | Skin care compositions and methods of use thereof |
| EP2116237A1 (en) | 2008-08-05 | 2009-11-11 | Polichem SA | Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| US8927522B2 (en) | 2008-10-14 | 2015-01-06 | Solazyme, Inc. | Microalgal polysaccharide compositions |
| US8557249B2 (en) | 2008-11-07 | 2013-10-15 | Solazyme, Inc. | Cosmetic compositions comprising microalgal components |
| EP2329849B1 (en) | 2009-11-18 | 2015-04-29 | Galderma Research & Development | Combination of alpha-2 adrenergic receptor agonist and non-steroidal anti-inflammatory agent for treating or preventing an inflammatory skin disorder |
| US8394800B2 (en) | 2009-11-19 | 2013-03-12 | Galderma Laboratories, L.P. | Method for treating psoriasis |
| CA2790682C (en) | 2010-03-03 | 2020-11-24 | Neocutis Sa | Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds |
| US9180112B2 (en) * | 2010-03-23 | 2015-11-10 | Ermis Labs, LLC | Dermal compositions containing gorgonian extract |
| KR20150058551A (ko) | 2010-03-26 | 2015-05-28 | 갈데르마 리써어치 앤드 디벨로프먼트 | 모세혈관 확장증의 안전하고 유효한 치료를 위한 개선된 방법 및 조성물 |
| US8513247B2 (en) | 2010-03-26 | 2013-08-20 | Galderma Laboratories, L.P. | Methods and compositions for safe and effective treatment of erythema |
| US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
| PH12013500738A1 (en) | 2010-10-21 | 2016-08-05 | Galderma Sa | Brimonidine gel compositions and methods of use |
| EP2658522B1 (en) | 2010-12-30 | 2019-07-31 | Mary Kay Inc. | Multi-purpose cosmetic compositions |
| US11407713B2 (en) | 2011-01-03 | 2022-08-09 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
| US8933119B2 (en) | 2011-01-03 | 2015-01-13 | The William M. Yarbrough Foundation | Method for treating phytophotodermatitis |
| US11279674B2 (en) | 2011-01-03 | 2022-03-22 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactant and associated method of use |
| US10647668B2 (en) | 2011-01-03 | 2020-05-12 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactant and associated method of use |
| US9962361B2 (en) | 2011-01-03 | 2018-05-08 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
| US10640464B2 (en) | 2011-01-03 | 2020-05-05 | The William M. Yarbrough Foundation | Use of isothiocyanate functional surfactants as Nrf2 inducers to treat epidermolysis bullosa simplex and related diseases |
| US10308599B2 (en) | 2011-01-03 | 2019-06-04 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating the same, and associated methods of use |
| US10273205B2 (en) | 2011-01-03 | 2019-04-30 | The William M. Yarbrough Foundation | Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms |
| US8865765B2 (en) | 2011-01-12 | 2014-10-21 | The William M. Yarbrough Foundation | Method for treating eczema |
| US9532969B2 (en) | 2011-02-08 | 2017-01-03 | The William M. Yarbrough Foundation | Method for treating psoriasis |
| WO2013016072A1 (en) | 2011-07-22 | 2013-01-31 | Allergan, Inc. | Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
| MX2014004383A (es) | 2011-10-19 | 2014-11-12 | Galderma Sa | Metodo para reducir el enrojecimiento facial asociado con el uso sistemico de inhibidores de fosfodiesterasa tipo 5. |
| UA109359C2 (xx) | 2011-11-10 | 2015-08-10 | Лікування захворювань і станів шкіри 7-(1h-імідазол-4-ілметил)-5,6,7,8-тетрагідрохіноліном | |
| US9283217B2 (en) | 2011-11-10 | 2016-03-15 | Allergan, Inc. | Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions |
| US8877259B2 (en) | 2012-02-09 | 2014-11-04 | Mary Kay Inc. | Cosmetic formulation |
| US10335387B2 (en) | 2012-07-26 | 2019-07-02 | The William M. Yarbrough Foundation | Method for treating infectious diseases with isothiocyanate functional compounds |
| US10434082B2 (en) | 2012-07-26 | 2019-10-08 | The William M. Yarbrough Foundation | Isothiocyanate functional compounds augmented with secondary antineoplastic medicaments and associated methods for treating neoplasms |
| US9949943B2 (en) * | 2012-07-26 | 2018-04-24 | The William M. Yarbrough Foundation | Method for treating neurodegenerative diseases |
| US10434081B2 (en) | 2012-07-26 | 2019-10-08 | The William M. Yarbrough Foundation | Inhibitors of macrophage migration inhibitory factor |
| WO2014018874A1 (en) | 2012-07-26 | 2014-01-30 | The William M. Yarbrough Foundation | Method for treating skin cancer |
| US10080734B2 (en) | 2012-07-26 | 2018-09-25 | The William M. Yarbrough Foundation | Method for treating autism and other neurodevelopmental disorders |
| US9839621B2 (en) | 2012-07-26 | 2017-12-12 | The William M. Yarbrough Foundation | Method for treating bladder cancer |
| US10441561B2 (en) | 2012-07-26 | 2019-10-15 | The William M. Yanbrough Foundation | Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer |
| US9861645B2 (en) | 2012-12-28 | 2018-01-09 | Rak Holdings Llc | Anti-itch scalp treatment compositions and combinations |
| EP2996672A4 (en) | 2013-05-15 | 2016-11-02 | Terravia Holdings Inc | COSMETIC COMPOSITIONS WITH MICROALGEN OIL |
| WO2016007601A1 (en) | 2014-07-11 | 2016-01-14 | Mary Kay Inc. | Pore minimizer |
| GB2528482A (en) * | 2014-07-23 | 2016-01-27 | Skintech Life Science Ltd | Pharmaceutical agent |
| PY1917053A (es) * | 2018-03-09 | 2019-09-13 | Ocusoft Inc | Composiciones tópicas para el cuidado de la piel |
| US20250359574A1 (en) | 2024-05-22 | 2025-11-27 | Blue Evolution Inc. | Composition of and method of extraction of ulva gel from seaweed polysaccharide and protein |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR900007498B1 (ko) | 1987-06-18 | 1990-10-11 | 구레하 가가꾸 고교 가부시끼가이샤 | 다당류 및 그것을 활성성분으로 함유하는 항바이러스 약제 |
| US5306486A (en) | 1993-03-01 | 1994-04-26 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic sunscreen composition containing green tea and a sunscreen |
| FR2732221B1 (fr) | 1995-03-28 | 1997-04-25 | Oreal | Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue |
| US5624911A (en) | 1995-06-07 | 1997-04-29 | The Regents Of The University Of California | Ether derivatives of pseudopterosin |
| IL114267A0 (en) | 1995-06-22 | 1995-10-31 | Univ Ben Gurion | Antiviral agents |
| KR100556682B1 (ko) | 1995-09-01 | 2006-06-21 | 코스모페름 베.파우 | 스핑고이드염기의레티노일아미드계유도체 |
| US5885595A (en) | 1996-05-13 | 1999-03-23 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic composition with a retinol fatty acid ester |
| US5811114A (en) * | 1996-06-12 | 1998-09-22 | E-L Management Corp. | Stabilized hinokitiol and compositions containing same |
| US5728732A (en) | 1996-11-27 | 1998-03-17 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin treatment with salicylic acid esters and retinoids |
| CA2302561C (en) * | 1997-09-12 | 2006-02-14 | The Procter & Gamble Company | Cleansing and conditioning article for skin or hair |
| US20030059447A1 (en) | 1997-12-05 | 2003-03-27 | Johannes Wilhelmus J Lambers | Compositions comprising a combination of a free sphingoid base and a ceramide and uses thereof |
| US5972993A (en) | 1998-03-20 | 1999-10-26 | Avon Products, Inc. | Composition and method for treating rosacea and sensitive skin with free radical scavengers |
| WO2000001839A1 (en) | 1998-07-03 | 2000-01-13 | Cosmoferm B.V. | Improved microbial strains producing sphingoid bases |
| US5952372A (en) | 1998-09-17 | 1999-09-14 | Mcdaniel; William Robert | Method for treating rosacea using oral or topical ivermectin |
-
2001
- 2001-10-05 US US09/971,561 patent/US6680062B2/en not_active Expired - Lifetime
-
2002
- 2002-09-18 CA CA2461941A patent/CA2461941C/en not_active Expired - Fee Related
- 2002-09-18 EP EP02800840A patent/EP1441685B1/en not_active Expired - Lifetime
- 2002-09-18 AT AT02800840T patent/ATE414527T1/de not_active IP Right Cessation
- 2002-09-18 DE DE60229971T patent/DE60229971D1/de not_active Expired - Lifetime
- 2002-09-18 WO PCT/US2002/029722 patent/WO2003030813A2/en not_active Ceased
- 2002-09-18 JP JP2003533847A patent/JP3921202B2/ja not_active Expired - Fee Related
- 2002-09-18 AU AU2002334601A patent/AU2002334601B2/en not_active Ceased
- 2002-09-18 ES ES02800840T patent/ES2316647T3/es not_active Expired - Lifetime
-
2006
- 2006-08-22 JP JP2006225842A patent/JP2006306899A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2461941A1 (en) | Anti-irritating rosacea treatment | |
| ATE401089T1 (de) | Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen | |
| EP2961418B1 (en) | Acne solution | |
| WO2019199861A3 (en) | Hemp extract for treatment of pain in animals | |
| WO2004093569A1 (en) | Topical composition on the basis of honey | |
| JP2011522831A (ja) | ナノシルバーを含むニキビ治療用組成物及びその使用 | |
| CA2600384A1 (en) | Compositions and methods for treating acne | |
| CN110035797B (zh) | 用于治疗痤疮的具有益生元特性的协同草药组合物 | |
| DE60229431D1 (de) | Verwendungen von chitosanoligosacchariden | |
| JP2002526407A5 (OSRAM) | ||
| WO2007102090A3 (en) | Topical formulation | |
| WO2011104900A1 (ja) | 抗真菌剤 | |
| JP2005507903A5 (OSRAM) | ||
| US10071052B2 (en) | Method for the prevention and treatment of acne | |
| CN105749331A (zh) | 一种香紫苏伤口敷料及其制备方法 | |
| JP2008543902A5 (OSRAM) | ||
| CN103623152A (zh) | 一种祛痘、去痘印、祛除痤疮疤痕的药 | |
| JP2024516316A5 (OSRAM) | ||
| EP2588095B1 (en) | Composition for the treatment of acne vulgaris | |
| CA2489705A1 (en) | Use of amide derivative of ge 2270 factor a3 for the treatment of acne | |
| PH12022551384A1 (en) | Chronic wound healing composition and application thereof | |
| CN105030639B (zh) | 一种拔毒祛痘膏及其制备方法 | |
| KR20060021775A (ko) | 애완동물의 탈모, 모발손상, 피부 질환을 예방 및치료하는 애완동물용 모발 트리트먼트 및 입욕 보조제 | |
| US20240207345A1 (en) | Methods and compositions for treating hair loss | |
| JP2026506380A (ja) | 皮膚の状態または疾患を処置する方法 |